Efficacy of electroconvulsive therapy in treating auditory verbal hallucinations in a deaf patient with schizophrenia: A case report

Table 1 The patient’s drug treatment history

Time	Quetiapine extended-release tablets	Paliperidone extended-release tablets	Clozapine
March 4, 2024-March 5, 2024	50 mg/day	-	-
March 6, 2024-March 7, 2024	100 mg/day	-	-
March 8, 2024-March 10, 2024	150 mg/day	-	-
March 11, 2024-April 3, 2024	200 mg/day	-	-
March 9, 2024-March 14, 2024	-	3 mg/day	-
March 15, 2024-April 29, 2024	-	6 mg/day	-
April 4, 2024-April 5, 2024	-	-	25 mg/day
April 6, 2024-April 7, 2024	-	-	50 mg/day
April 8, 2024-April 11, 2024	-	-	100 mg/day
April 12, 2024-April 29, 2024	-	-	150 mg/day

Table 2 The patient’s modified electroconvulsive therapy treatment history

Time	MECT
April 2, 2024	First time
April 3, 2024	Second time
April 6, 2024	Third time
April 9, 2024	Fourth time
April 13, 2024	Fifth time
April 16, 2024	Sixth time

MECT: Modified electroconvulsive therapy.